Skip to content

Drug interactions

Dasatinib + Repaglinide

Severity: Minor

Dasatinib and Repaglinide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dasatinib is a weak CYP3A4 inhibitor and may modestly raise repaglinide concentrations. This could increase hypoglycemia risk, although clinical data are limited.

What this interaction means in plain words

Dasatinib and Repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dasatinib belongs to Oncology; Repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Dasatinib weakly inhibits CYP3A4, reducing repaglinide metabolism.

What to do

Monitor blood glucose after dasatinib is started and reduce the repaglinide dose if low readings occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Repaglinide?

MediHelp rates the interaction as minor. Dasatinib and Repaglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dasatinib is a weak CYP3A4 inhibitor and may modestly raise repaglinide concentrations. This could increase hypoglycemia risk, although clinical data are limited.

How serious is the interaction between Dasatinib and Repaglinide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after dasatinib is started and reduce the repaglinide dose if low readings occur.

What other medicines interact with Repaglinide?

MediHelp also lists interactions of Repaglinide with, for example, Gemfibrozil, Clarithromycin, Clopidogrel. The full list is on the Repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in